Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uffe Bodtger

Showing results (101-110 of 141) with videos related to

Pageof 15
Sort By:
Respiration; International Review of Thoracic Diseases|January 22, 2024
Consequences of Losing Incidental Pulmonary Nodules to Follow-Up: Unmonitored Nodules Progressing to Stage IV Lung CancerMorten Borg, Katrine Kristensen, Gitte Alstrup, et al.
European Clinical Respiratory Journal|December 12, 2018
Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma - a systematic review and meta-analysisDaniel P Henriksen, Uffe Bodtger, Kirsten Sidenius, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 23, 2020
Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthmaDaniel P Henriksen, Uffe Bodtger, Kirsten Sidenius, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 5, 2019
Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in DenmarkDaniel Bech Rasmussen, Uffe Bodtger, Morten Lamberts, et al.
Diagnostics (Basel, Switzerland)|June 19, 2024
Patient-Reported Outcome Measures in Patients with and without Non-Expandable Lung Secondary to Malignant Pleural Effusion-A Single-Centre Observational StudyJesper Koefod Petersen, Katrine Fjaellegaard, Daniel Bech Rasmussen, et al.
Acta Oncologica (Stockholm, Sweden)|September 1, 2023
Who are the vulnerable lung cancer patients at risk for not receiving first-line curative or palliative treatment?Rikke Langballe, Erik Jakobsen, Maria Iachina, et al.
Annals of the American Thoracic Society|May 19, 2022
Breathing Exercises for Patients with Asthma in Specialist Care: A Multicenter Randomized Clinical TrialKaren H Andreasson, Søren T Skou, Charlotte S Ulrik, et al.
Lung Cancer (Amsterdam, Netherlands)|November 14, 2021
Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysisKatrine Fjaellegaard, Jesper Koefod Petersen, Simon Reuter, et al.
Journal of Thoracic Disease|August 10, 2023
Safety and feasibility of oesophageal ultrasound for the work-up of thoracic malignancy in patients with respiratory impairmentIda Skovgaard Christiansen, Uffe Bodtger, Rafi Nessar, et al.
European Clinical Respiratory Journal|November 12, 2024
Translation and cross-cultural adaptation of the self evaluation of breathing questionnaire (SEBQ) into DanishKaren Hjerrild Andreasson, Julie Sandell Jacobsen, Anja Leth Egsgaard, et al.
Pageof 15

Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
Respiration; International Review of Thoracic Diseases|January 22, 2024
Consequences of Losing Incidental Pulmonary Nodules to Follow-Up: Unmonitored Nodules Progressing to Stage IV Lung CancerMorten Borg, Katrine Kristensen, Gitte Alstrup, et al.
European Clinical Respiratory Journal|December 12, 2018
Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma - a systematic review and meta-analysisDaniel P Henriksen, Uffe Bodtger, Kirsten Sidenius, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 23, 2020
Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthmaDaniel P Henriksen, Uffe Bodtger, Kirsten Sidenius, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 5, 2019
Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in DenmarkDaniel Bech Rasmussen, Uffe Bodtger, Morten Lamberts, et al.
Diagnostics (Basel, Switzerland)|June 19, 2024
Patient-Reported Outcome Measures in Patients with and without Non-Expandable Lung Secondary to Malignant Pleural Effusion-A Single-Centre Observational StudyJesper Koefod Petersen, Katrine Fjaellegaard, Daniel Bech Rasmussen, et al.
Acta Oncologica (Stockholm, Sweden)|September 1, 2023
Who are the vulnerable lung cancer patients at risk for not receiving first-line curative or palliative treatment?Rikke Langballe, Erik Jakobsen, Maria Iachina, et al.
Annals of the American Thoracic Society|May 19, 2022
Breathing Exercises for Patients with Asthma in Specialist Care: A Multicenter Randomized Clinical TrialKaren H Andreasson, Søren T Skou, Charlotte S Ulrik, et al.
Lung Cancer (Amsterdam, Netherlands)|November 14, 2021
Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysisKatrine Fjaellegaard, Jesper Koefod Petersen, Simon Reuter, et al.
Journal of Thoracic Disease|August 10, 2023
Safety and feasibility of oesophageal ultrasound for the work-up of thoracic malignancy in patients with respiratory impairmentIda Skovgaard Christiansen, Uffe Bodtger, Rafi Nessar, et al.
European Clinical Respiratory Journal|November 12, 2024
Translation and cross-cultural adaptation of the self evaluation of breathing questionnaire (SEBQ) into DanishKaren Hjerrild Andreasson, Julie Sandell Jacobsen, Anja Leth Egsgaard, et al.
Pageof 15